What is the address of DR.PAULIEN VAN ACKER, NEFROLOGIE?

The registered office of DR.PAULIEN VAN ACKER, NEFROLOGIE is located at Hondelee 62, 9052 Gent.

Is DR.PAULIEN VAN ACKER, NEFROLOGIE still active?

Yes. According to the CBE (16 September 2026) DR.PAULIEN VAN ACKER, NEFROLOGIE is active, legal situation “Normale toestand”, started on 17 January 2022.

Is DR.PAULIEN VAN ACKER, NEFROLOGIE registered on Peppol?

Yes, DR.PAULIEN VAN ACKER, NEFROLOGIE is registered on the Peppol network with ID 0208:0780524158.

What is the enterprise number of DR.PAULIEN VAN ACKER, NEFROLOGIE?

The enterprise number of DR.PAULIEN VAN ACKER, NEFROLOGIE is BE0780524158.

When was DR.PAULIEN VAN ACKER, NEFROLOGIE founded?

DR.PAULIEN VAN ACKER, NEFROLOGIE was founded on 17 January 2022.

Who are the directors of DR.PAULIEN VAN ACKER, NEFROLOGIE?

According to the 2025 annual accounts, the directors of DR.PAULIEN VAN ACKER, NEFROLOGIE are: Paulien Van Acker.

Is DR.PAULIEN VAN ACKER, NEFROLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 January 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR.PAULIEN VAN ACKER, NEFROLOGIE make in 2025?

DR.PAULIEN VAN ACKER, NEFROLOGIE posted a profit after taxes of € 218,015 in financial year 2025.

What is the revenue of DR.PAULIEN VAN ACKER, NEFROLOGIE?

As a small company, DR.PAULIEN VAN ACKER, NEFROLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 287,946.

DR.PAULIEN VAN ACKER, NEFROLOGIE (Private Limited) - Gent

Dossier DR.PAULIEN VAN ACKER, NEFROLOGIE, printed on 16 September 2026 from databakkes.be/en/0780524158/dr-paulien-van-acker-nefrologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR.PAULIEN VAN ACKER, NEFROLOGIE from Gent, company number BE0780524158, closed financial year 2025 with a result of € 218,015 after tax. For that financial year DR.PAULIEN VAN ACKER, NEFROLOGIE recorded a gross margin of € 287,946 and equity of € 85,803. Compared with financial year 2024, the result moved from € 90,972 to € 218,015. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.

What it is worth Healthy

€ 85,803

▼ 48% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 218,015

▲ 140% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 137,703

▲ 46% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 298,606 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 462

▼ 72% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 50,040

▲ € 45,361 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 77,701 Gross margin 2022: € 77,701 First fiscal year in the series	€ 17,782 Gross margin 2023: € 17,782 ▼ 77% vs 2022 (€ 77,701) Unfavourable step	€ 117,290 Gross margin 2024: € 117,290 ▲ € 99,508 vs 2023 (€ 17,782) Favourable step	€ 287,946 Gross margin 2025: € 287,946 ▲ 145% vs 2024 (€ 117,290) Favourable step	▲ 145%
Profit after taxes	€ 61,099 Profit after taxes 2022: € 61,099 First fiscal year in the series	€ 12,323 Profit after taxes 2023: € 12,323 ▼ 80% vs 2022 (€ 61,099) Unfavourable step	€ 90,972 Profit after taxes 2024: € 90,972 ▲ € 78,649 vs 2023 (€ 12,323) Favourable step	€ 218,015 Profit after taxes 2025: € 218,015 ▲ 140% vs 2024 (€ 90,972) Favourable step	▲ 140%
Equity	€ 63,099 Equity 2022: € 63,099 First fiscal year in the series	€ 75,422 Equity 2023: € 75,422 ▲ 20% vs 2022 (€ 63,099) Favourable step	€ 166,394 Equity 2024: € 166,394 ▲ 121% vs 2023 (€ 75,422) Favourable step	€ 85,803 Equity 2025: € 85,803 ▼ 48% vs 2024 (€ 166,394) Unfavourable step	▼ 48%
Total debts	€ 6,138 Total debts 2022: € 6,138 First fiscal year in the series	€ 7,290 Total debts 2023: € 7,290 ▲ 19% vs 2022 (€ 6,138) Unfavourable step	€ 13,103 Total debts 2024: € 13,103 ▲ 80% vs 2023 (€ 7,290) Unfavourable step	€ 192,117 Total debts 2025: € 192,117 ▲ € 179,014 vs 2024 (€ 13,103) Unfavourable step	▲ € 179,014
Cash	€ 61,411 Cash 2022: € 61,411 First fiscal year in the series	€ 68,414 Cash 2023: € 68,414 ▲ 11% vs 2022 (€ 61,411) Favourable step	€ 94,591 Cash 2024: € 94,591 ▲ 38% vs 2023 (€ 68,414) Favourable step	€ 137,703 Cash 2025: € 137,703 ▲ 46% vs 2024 (€ 94,591) Favourable step	▲ 46%
Retained profit	€ 61,099 Retained profit 2022: € 61,099 First fiscal year in the series	€ 73,422 Retained profit 2023: € 73,422 ▲ 20% vs 2022 (€ 61,099) Favourable step	€ 164,394 Retained profit 2024: € 164,394 ▲ 124% vs 2023 (€ 73,422) Favourable step	€ 83,803 Retained profit 2025: € 83,803 ▼ 49% vs 2024 (€ 164,394) Unfavourable step	▼ 49%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 298,606 Dividend 2025: € 298,606 Unchanged (€ 0) Unchanged
Balance sheet total	€ 69,238 Balance sheet total 2022: € 69,238 First fiscal year in the series	€ 82,712 Balance sheet total 2023: € 82,712 ▲ 19% vs 2022 (€ 69,238) Unchanged	€ 179,498 Balance sheet total 2024: € 179,498 ▲ 117% vs 2023 (€ 82,712) Unchanged	€ 277,920 Balance sheet total 2025: € 277,920 ▲ 55% vs 2024 (€ 179,498) Unchanged	▲ 55%

Key figures of DR.PAULIEN VAN ACKER, NEFROLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR.PAULIEN VAN ACKER, NEFROLOGIE?

What happened at DR.PAULIEN VAN ACKER, NEFROLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 29, 2026 New annual accounts for financial year 2025: profit of € 218,015 (▲ 140% vs 2024). Source: NBB ↗
Jan 17, 2022 New establishment in Gent. KBO
Jan 17, 2022 Start of the company according to the CBE. KBO

In short

From € 61,099 profit in 2022 to € 218,015 profit in 2025.

Paid € 111,349 in corporate taxes since 2022.

Best year ever: 2025, with € 218,015 profit.

Paid out € 298,606 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR.PAULIEN VAN ACKER, NEFROLOGIE? We notify you, reason included.

Follow DR.PAULIEN VAN ACKER, NEFROLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit